GlassScriptPhysician profile
Asit V Shah
NPI 1417058884
$1,326.56
in general payments reported to CMS, 2019-2025
13 companies · $327 in 2025
The $327 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.81 · 2020: $17.46 · 2021: $209 · 2022: $385 · 2023: $167 · 2024: $135 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $503.39 | 2021-2025 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $208.21 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $191.93 | 2019-2025 | Gardasil 9, Proquad, M-M-R II |
| Ironshore Pharmaceuticals INC. | $135.22 | 2022-2024 | Jornay Pm |
| Cranial Technologies, INC | $73.81 | 2021-2023 | Doc Band |
| Collegium Pharmaceutical, INC. | $38.65 | 2025 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $37.85 | 2024-2025 | Ycanth |
| Pfizer INC. | $29.71 | 2019-2022 | |
| Sobi, INC | $25.90 | 2023 | |
| Lnhc, INC | $23.50 | 2025 | Zelsuvmi |
| Alexion Pharmaceuticals, INC. | $23.23 | 2025 | |
| Hologic Sales and Service, LLC | $21.45 | 2019 | |
| Seqirus USA INC | $13.71 | 2024 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.